Scientific Company Directory
The latest research, products, and discoveries from the science industry’s leading companies and company divisions.
NEW
Scientific Products
From innovative tools to essential equipment and supplies, find everything you need to advance your research on our new Scientific Products page.
Search Scientific Products
Olink's mission is to accelerate proteomics together with the scientific community, to understand real-time biology and gain actionable insights into human health and disease. We believe this will drive the development of better, more targeted therapies and help revolutionize future healthcare through the implementation of precision medicine. Learn more about us below!
Andor are global leaders in the development and manufacture of high performance scientific digital cameras, microscopy systems and spectrographs for academic, industrial and government applications. Through continuous dialogue with our customers and strong teamwork, we continue to innovate ground-breaking products, improving the world in which we live.
OriGene Technologies was founded as a research tool company focused on the creation of the large commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based tools have enabled the identification of relevant drug targets through system biology approaches. OriGene's vision is to prepare comprehensive, genome wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research.
OriGene Technologies uses high-throughput, genome wide approach to develop products for pharmaceutical, biotechnology, and academic research. Our flagship product is the cDNA clone collection, a searchable gene bank of over 40,000 human full-length TrueClone cDNA collection and over 35,000 human TrueORF cDNA clones. From our TrueORF cDNA clones, we have developed the broad offering of full length human proteins, such as "MVPro" proteins, expressed in mammalian cells, ideal for functional studies. In 2010, OriGene initiated the TrueMAB™ project to develop mouse monoclonal antibodies against protein antigens with the goal to develop protein assays for every human protein. OriGene also began the TrueRAB™ project to develop single B cell cloning technology for the generation of recombinant rabbit monoclonal antibodies with high affinity and against targets with low immunogenicity in mouse system.
In addition, OriGene offers different gene expression products such as TissueScan cancer tissue qPCR arrays and tissue biorepository for biomarker discovery and validation
OriGene is committed to its mission to be "Your Gene Company", in supplying everything a researcher needs for gene based research.
For more information, please visit us at www.origene.com
Oxford Nanopore Technologies has developed the world's first and only nanopore DNA sequencer, the MinION. The MinION is a portable, real time, long-read, low cost device that has been designed to bring easy biological analyses to anyone, whether in scientific research, education or a range of real world applications such as disease/pathogen surveillance, environmental monitoring, food chain surveillance, self-quantification or even microgravity biology.
Ortho Clinical Diagnostics serves the transfusion medicine community and laboratories around the world. We're a leading provider of total solutions for screening, diagnosing, monitoring and confirming diseases early, before they put lives at risk.
Headquartered in Raritan, NJ, with manufacturing operations in Rochester NY, Pompano Beach, FL and Cardiff, Wales, Ortho Clinical Diagnostics has more than 2,500 employees worldwide. We are dedicated to investing significant resources to continuously improve our products and develop solutions to address unmet medical needs.
Our single focus is to help hospitals, laboratories and blood centers worldwide deliver results that help patients experience a better quality of life.
At Olympus, we are focused on improving people's lives every day. We do this through innovation. As a precision technology leader, we design and deliver innovative solutions in our core business areas: Medical and Surgical Products, Life Science Imaging Systems, Industrial Measurement and Imaging Instruments and Cameras and Audio Products.
Our products are used to capture images of our world from the microscopic to the panoramic. They're instrumental in furthering scientific research, travel inside the human body to help diagnose, treat and prevent illness, and document your life with artistic freedom.
Most of all, we're dedicated to helping people enjoy the continuum of life. Since 1919, Olympus has developed innovative technology solutions that contribute positively to society. Our commitment to customers and our social responsibility are the cornerstone of everything we do.
Oxford Instruments Asylum Research is the technology leader in atomic force microscopy (AFM) for life science and materials science research. Our range of AFMs for life science research includes the MFP-3D BIO that enables combined AFM and light microscopy and the Cypher VRS video-rate AFM that enables imaging of dynamics at rates over 10 frames/second. Visit us to learn how AFM can help drive your cell biology research projects. https://AFM.oxinst.com
Oxford Instruments NanoAnalysis offers a range of analysis, imaging, and sample preparation solutions for electron microscopes, including energy dispersive x-ray spectroscopy (EDS) optimized for life sciences. Our award-winning Ultim Extreme EDS complements and enhances conventional biological imaging techniques by providing accurate compositional information with unprecedented spatial resolution, speed and elemental sensitivity. Cryo-enabled OmniProbe nanomanipulators enable in situ lift-out, a key role in the workflow for preparing samples for Cryo-TEM. New Relate software enables correlation, visualization, and analysis of combined AFM, EM, EDS and EBSD data. https://nano.oxinst.com/
At ODN, our purpose is to simplify your out-of-home (OOH) buying experience and boost your results while lowering costs.
That goes beyond buying traditional OOH placements. Now, we also bring brands to life through creative, shareable experiences that captivate and move consumers to action. And, we take care of Point of Purchase (POP) on-demand printing, too. All in one place. It's out-of-home simplified.
Omura is an innovative Heat-Not-Burn technology company, created by whole flower enthusiasts to allow consumers to vaporize a small amount of whole flower cannabis super efficiently for a controlled, balanced, perfectly dosed, entourage effect.
The word 'Omura' comes from the idea of the balance between precision and purity and is the ethos of the brand. Precision in our dosed Flowersticks for a precisely controlled experience, and purity in our use of only 100% whole flower for a pure and clean experience.
Omura's first of its kind patented Heat-Not-Burn technology and pre-filled Flowersticks give consumers the ability to enjoy combustion-free whole flower anytime, anywhere with an effect that leaves them feeling balanced and in control.
Omura partners with flower brands in both the THC and Hemp CBD space. Selling Hemp CBD Flowersticks in select retailers and on Omuracbd.com. Omura is currently partnering with THC brands in California and Massachusetts.
Our mission is to serve and empower women involved in the Oklahoma cannabis industry no matter what race, religion, or socioeconomic status. We will continually strive to cultivate an environment of collective cooperation among all women. Our passion to serve others and advocate for legalization and proper regulation of cannabis and to ensure Oklahoma Women in Cannabis set the stage to advance health and overall quality of life.
OncoSpherix, Inc., based in Atlanta, Ga, is a pre-clinical stage oncology drug development company that is advancing a proprietary platform of first-in-class small molecule therapeutics that are designed to improve the quality of life and survival for people with many forms of cancer by targeting a common feature of solid tumors: the activation of hypoxia inducible factor-1 (HIF-1). Nearly all solid cancers grow faster than their blood supplies, leading to regions of low oxygen in the tumors and HIF activation. The HIFs in turn induce the expression of over 100 genes that help tumor cells survive and spread. OncoSpherix has several classes of small molecules that block activation of HIF-1 through novel mechanisms. OncoSpherix’s lead clinical candidate has been shown in mouse models to reduce primary tumor growth, inhibit metastasis, and prolong survival in many types of cancer (glioblastoma, pancreatic cancer, uveal melanoma, lung cancer, breast cancer). OncoSpherix intends to advance its lead candidate in one or more of these indications, in combination with agents that show therapeutic synergy while being well-tolerated.as part of the combination.
